 |
|
©2000-2010 Intelligent Systems |
Sharon Correia Schwarz Pharma Reports Positive Results for Rotigotine Phase IIb Trials to Treat Restless Legs Syndrome Aderis Pharmaceuticals partner, Schwarz Pharma, announces that the multinational Phase IIb trial with rotigotine has shown a statistically significant and clinically relevant reduction of RLS symptoms. Hopkinton, MA - Jul 12, 2004 - Aderis Pharmaceuticals partner, Schwarz Pharma, reports positive Phase IIb results for rotigotine in a double blind, placebo controlled clinical trial of 310 patients with moderate to very severe Restless Legs Syndrome.Read the complete release from Schwarz Pharma. # # # # |
|
